Introduction
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, accounting for numerous hospital admissions. In this essay, we will discuss the history of present illness (HPI) and comprehensive clinical examination/review of systems (ROS) for a patient with suspected CVD. We will explore the pathophysiology of the admitting diagnosis and past medical/surgical histories, perform a socioeconomic/psychosocial assessment, assess teaching needs and client education, determine interprofessional consults and collaborative plans, identify multidisciplinary client outcomes, analyze laboratory results and diagnostic procedures, review the patient’s medication list, recognize pertinent assessment cues, prioritize clinical judgments, generate SMART goals/outcomes, implement interventions, and evaluate the effectiveness of the care plan. All information will be supported with evidence-based citations.
[order_button_a]
History of Present Illness (HPI) and Review of Systems (ROS)
History of Present Illness (HPI)
The patient, a 60-year-old male, presents with complaints of chest pain, shortness of breath, and fatigue. The chest pain is described as a pressure-like sensation, radiating to the left arm, and aggravated by physical exertion. He reports experiencing these symptoms for the past two weeks, with increasing frequency and severity. The patient denies any associated symptoms such as nausea, diaphoresis, or lightheadedness. However, he does mention occasional palpitations and dizziness.
Evidence-based rationale
According to the American Heart Association (AHA), chest pain is the hallmark symptom of coronary artery disease (CAD), often caused by reduced blood flow to the heart due to atherosclerotic plaque formation in the coronary arteries (Benjamin et al., 2019). The description of chest pain radiating to the left arm is a typical feature of angina pectoris, a common presentation in CAD (AHA, 2021). The association of chest pain with physical exertion suggests the presence of stable angina, as exertional activities increase the myocardial oxygen demand, which cannot be met adequately due to narrowed coronary arteries.
Review of Systems (ROS)
Upon reviewing the patient’s systems, several findings are noted related to the cardiovascular system. The patient reports experiencing shortness of breath, especially during walking or climbing stairs. This symptom indicates possible cardiac decompensation, as reduced cardiac output fails to meet the body’s demands, leading to dyspnea. Additionally, the patient mentions feeling fatigued even after minimal activity, which may result from the compromised cardiac function.
The patient also notes occasional palpitations, suggesting cardiac arrhythmias as a potential concern. Furthermore, he reports episodes of dizziness, which may be associated with reduced cerebral perfusion secondary to impaired cardiac output.
Evidence-based rationale
Shortness of breath and fatigue are common symptoms of heart failure, a complication of CAD. The American College of Cardiology/American Heart Association (ACC/AHA) guidelines emphasize that dyspnea is a cardinal symptom of heart failure and indicates the need for further evaluation (Mayo Clinic, 2021). Palpitations and dizziness can be attributed to cardiac arrhythmias, which may arise due to altered electrical conduction pathways in the heart (ACC/AHA, 2017).
In summary, the patient’s HPI and ROS present key symptoms and findings that are consistent with suspected coronary artery disease (CAD) and its potential complications. A thorough understanding of these symptoms and their associated evidence-based rationales is crucial for accurate diagnosis and appropriate management of the patient’s cardiovascular health. Further diagnostic evaluations, such as electrocardiography and stress testing, along with collaboration with a cardiologist, will aid in confirming the diagnosis and formulating an effective plan of care.
Pathophysiology of Admitting Diagnosis (Coronary Artery Disease – CAD)
Coronary Artery Disease (CAD) is a condition characterized by the narrowing and hardening of the coronary arteries that supply oxygen and nutrients to the heart muscle. The primary underlying cause of CAD is atherosclerosis, a progressive condition where fatty deposits (atherosclerotic plaques) build up within the arterial walls, leading to their narrowing and reduced blood flow to the heart.
The pathophysiology of CAD begins with damage to the inner lining of the coronary arteries. This damage can be caused by various factors, including high blood pressure, smoking, high cholesterol levels, and inflammation. Once the arterial wall is injured, circulating lipids, especially low-density lipoproteins (LDL cholesterol), start to accumulate in the damaged area, initiating the formation of fatty streaks.
Over time, the fatty streaks can evolve into atherosclerotic plaques, which consist of a core of cholesterol and lipid deposits covered by a fibrous cap. The formation of plaques narrows the arterial lumen, restricting blood flow to the heart muscle during periods of increased demand, such as exercise or stress. This reduced blood flow can lead to angina (chest pain) and, if left untreated, may eventually result in a myocardial infarction (heart attack).
In some cases, the atherosclerotic plaques can become unstable and rupture, leading to the formation of blood clots (thrombosis). These clots can completely occlude the narrowed coronary artery, resulting in an acute coronary syndrome (ACS) such as unstable angina or a heart attack.
Past Medical/Surgical Histories
The patient’s past medical/surgical histories are essential in understanding their overall health status and potential risk factors for CAD. Common medical conditions that increase the risk of CAD include hypertension, diabetes mellitus, and dyslipidemia. Hypertension, or high blood pressure, can cause chronic damage to the arterial walls, promoting atherosclerosis. Diabetes mellitus, especially if poorly controlled, can accelerate atherosclerosis by causing inflammation and damaging blood vessels. Dyslipidemia, characterized by high levels of LDL cholesterol and low levels of high-density lipoprotein (HDL cholesterol), directly contributes to the formation of atherosclerotic plaques.
Additionally, a history of smoking is a significant risk factor for CAD, as it not only damages the arterial walls but also promotes inflammation and oxidative stress, further contributing to the development of atherosclerosis.
Surgical histories, such as previous coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) with stent placement, may indicate a history of severe CAD and provide insights into the extent of coronary artery disease in the patient.
Overall, understanding the pathophysiology of CAD and considering the patient’s past medical/surgical histories are crucial in formulating a comprehensive plan of care for managing the patient’s cardiovascular health and preventing further complications. By addressing modifiable risk factors and promoting lifestyle modifications, healthcare providers can effectively manage CAD and improve the patient’s overall cardiovascular outcomes.
Socioeconomic/Psychosocial Assessment
The patient is married, lives with his spouse, and is financially stable. However, he expresses fear and anxiety about his diagnosis and its impact on his family. According to Saravanan et al., patients with CVD often experience psychological distress, which can negatively affect their outcomes and adherence to treatment plans (Saravanan et al., 2020). Identifying and addressing these psychosocial concerns are crucial for improving patient outcomes.
Teaching Assessment & Client Education
To improve the patient’s health literacy and self-care capabilities, a comprehensive client education plan is essential. Visual aids and written materials can help the patient understand the importance of lifestyle modifications and medication adherence. According to Plata et al., educating patients with CVD about their condition and treatment can lead to better medication adherence and lifestyle changes (Plata et al., 2018).
Interprofessional Consults and Collaborative Plan
Collaboration with a cardiologist and a registered dietitian is critical for the patient’s care. The cardiologist will provide specialized management for CAD, while the dietitian will assist in developing a heart-healthy diet plan. According to Lichtenstein et al., collaborative care involving a multidisciplinary team improves patient outcomes in managing CVD risk factors (Lichtenstein et al., 2019).
Multidisciplinary Client Outcome and Discharge Planning/Referrals
Given the complexity of the patient’s condition and the importance of a holistic approach to managing cardiovascular disease, a multidisciplinary team of healthcare professionals will collaborate to achieve the best possible outcome for the patient. The multidisciplinary team may include the following healthcare professionals:
Cardiologist: The cardiologist will play a central role in the patient’s care, overseeing the diagnostic evaluations, interpreting test results, and determining the appropriate medical management for the patient’s CAD. They will also guide the patient’s treatment plan, including medication adjustments and potential interventions such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) if necessary (Benjamin et al., 2019).
Cardiac Nurse: The cardiac nurse will closely monitor the patient’s vital signs, cardiac rhythm, and response to medications. They will provide patient education on lifestyle modifications, medication adherence, and recognizing early signs of complications. The cardiac nurse will also coordinate care between the various members of the healthcare team (Jandee et al., 2017).
Registered Dietitian: The registered dietitian will work with the patient to develop a personalized heart-healthy diet plan. They will educate the patient on the importance of maintaining a balanced diet low in saturated fats, sodium, and added sugars while emphasizing the inclusion of fruits, vegetables, whole grains, and lean proteins (Lichtenstein et al., 2019).
Physical Therapist: The physical therapist will design an exercise program tailored to the patient’s capabilities and limitations. They will focus on increasing cardiovascular fitness, improving strength, and promoting overall physical well-being. Regular exercise can help manage CAD risk factors and enhance the patient’s quality of life (Gibbons et al., 2017).
Mental Health Specialist: A mental health specialist, such as a psychologist or counselor, may be involved to address the patient’s emotional well-being and coping mechanisms. Cardiovascular disease can lead to anxiety and depression, and addressing these psychosocial factors can improve the patient’s overall cardiovascular health (Saravanan et al., 2020).
Pharmacist: The pharmacist will review the patient’s medication list, ensure appropriate dosages, and check for potential drug interactions. They will provide medication counseling to the patient and answer any questions or concerns related to the prescribed medications (Plata et al., 2018).
[order_button_b]
Discharge Planning and Referrals
Discharge planning is a critical aspect of the patient’s care to ensure a smooth transition from the hospital setting to the community. The multidisciplinary team will collaborate to develop a comprehensive discharge plan tailored to the patient’s specific needs and circumstances. The discharge plan may include the following components:
Medication Management: The patient will be provided with a detailed list of medications, dosages, and instructions for adherence. The pharmacist will review the medication plan, and any necessary adjustments will be communicated to the patient (Ridker et al., 2018).
Lifestyle Modifications: The patient will receive extensive education on lifestyle modifications, including dietary changes, regular exercise, smoking cessation, and stress management techniques. The registered dietitian, physical therapist, and mental health specialist will provide support and guidance in implementing these changes (Krumholz et al., 2018).
Follow-up Appointments: The patient will be scheduled for follow-up appointments with the cardiologist and other healthcare professionals as needed. Regular check-ups are essential for monitoring progress, adjusting treatment plans, and addressing any new concerns that may arise (Calhoun et al., 2018).
Home Care Services: If necessary, home care services may be arranged to provide additional support and monitoring during the patient’s recovery period.
Support Groups: Referrals to local support groups or community resources focused on cardiovascular health may be provided to offer the patient additional encouragement and social support.
By engaging a multidisciplinary team and developing a comprehensive discharge plan, the patient’s transition from the hospital to the community will be seamless, ensuring ongoing care and support to manage their cardiovascular disease effectively and enhance their overall well-being.
Labs
The patient’s laboratory results show elevated LDL cholesterol levels and blood pressure, consistent with his hypertension and high cholesterol history. Monitoring these levels is vital in assessing his response to treatment and disease progression. Regular laboratory monitoring helps in adjusting medication dosages and lifestyle modifications (Khan et al., 2018).
Diagnostics/Procedures
Diagnostic tests like electrocardiography (ECG) and stress testing will be conducted to evaluate the patient’s heart function and assess exercise tolerance. These tests aid in diagnosing CAD and determining its severity. According to Gibbons et al., stress testing is useful in identifying CAD and guiding treatment decisions (Gibbons et al., 2017).
Medications
The patient’s medication list includes aspirin, statins, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors. Aspirin reduces clot formation, statins lower cholesterol levels, beta-blockers reduce heart workload, and ACE inhibitors control blood pressure. Ensuring medication adherence is crucial for disease management. According to Choudhry et al., adherence to prescribed medications is associated with a reduced risk of adverse outcomes in patients with CVD (Choudhry et al., 2019).
Recognition of Cues
The patient’s chest pain, shortness of breath, and fatigue are critical assessment cues that require immediate attention. These symptoms are relevant to the cardiovascular system and indicate possible CAD. According to the American Heart Association (AHA), chest pain and shortness of breath are cardinal symptoms of CAD and require prompt evaluation and management (AHA, 2021).
Analysis of Cues
The analysis of the patient’s cues supports the prioritized client needs and plan of care. The symptoms align with the diagnosis of CAD and warrant interventions to manage the disease effectively. According to Krumholz et al., prompt recognition and treatment of CAD symptoms improve patient outcomes and reduce the risk of adverse events (Krumholz et al., 2018).
Prioritization of Hypotheses (Clinical Judgments)
Based on the patient’s symptoms, risk factors, and psychosocial concerns, the priority nursing clinical judgments include promoting cardiovascular health, reducing chest pain, improving exercise tolerance, and addressing anxiety. According to Tung et al., a comprehensive nursing care plan targeting these priorities can lead to improved patient outcomes and quality of life (Tung et al., 2021).
Generation of Solutions (S.M.A.R.T Goals/Outcomes)
The SMART goals/outcomes include reducing LDL cholesterol levels by 20% within three months, achieving blood pressure control below 130/80 mmHg within six weeks, and increasing exercise tolerance to 20 minutes of moderate activity daily within two months. These goals are time-limited, specific, measurable, attainable, and relevant, aligning with evidence-based recommendations for managing CVD (Ridker et al., 2018).
Implementation of Actions (Interventions)
To address the patient’s presenting symptoms, manage coronary artery disease (CAD), and promote cardiovascular health, the multidisciplinary team will implement a series of evidence-based interventions. These interventions will be individualized, prioritized, and specific to the patient’s needs. The interventions will aim to achieve the patient’s goals, improve their quality of life, and prevent further complications. Some of the key interventions include:
Medication Management: The patient will be started on appropriate medications to manage CAD and its risk factors. These may include antiplatelet agents (e.g., aspirin), beta-blockers, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), and statins to reduce cholesterol levels. The pharmacist will ensure the patient understands the importance of medication adherence and will monitor for any side effects or drug interactions.
Lifestyle Modifications: The registered dietitian will work with the patient to develop a heart-healthy diet plan that emphasizes the consumption of fruits, vegetables, whole grains, and lean proteins while limiting saturated fats, sodium, and added sugars. The physical therapist will design an exercise program tailored to the patient’s capabilities and preferences, with a focus on aerobic activities to improve cardiovascular fitness. Smoking cessation counseling and support will be provided to help the patient quit smoking.
Cardiac Rehabilitation: The patient will be referred to a cardiac rehabilitation program, where they will receive supervised exercise training, education on heart-healthy behaviors, and psychosocial support. Cardiac rehabilitation has been shown to reduce the risk of cardiovascular events and improve functional capacity in patients with CAD (Anderson et al., 2016).
Stress Management: The mental health specialist will provide counseling and stress management techniques to help the patient cope with the emotional impact of CAD and reduce stress-related triggers for angina episodes.
Education and Self-Management: The cardiac nurse and other team members will provide extensive education to the patient and their family about CAD, risk factors, warning signs of complications, and the importance of adhering to the treatment plan. The patient will be encouraged to actively participate in their care and self-monitor for any changes in symptoms.
Monitoring and Follow-up: The patient will be closely monitored during their hospital stay and after discharge. Vital signs, cardiac rhythm, and response to medications will be regularly assessed. The healthcare team will schedule follow-up appointments to evaluate progress, adjust the treatment plan as needed, and address any concerns.
Collaboration with Community Resources: The team will collaborate with community resources, such as support groups and local organizations focused on cardiovascular health, to provide additional support and education to the patient beyond the hospital setting.
By implementing these evidence-based interventions, the multidisciplinary team aims to improve the patient’s cardiac health, manage their symptoms, and reduce the risk of future cardiovascular events. The coordinated efforts of the team will empower the patient to actively participate in their care, leading to better outcomes and an improved quality of life.
Evaluation
The criteria for evaluation include tracking LDL cholesterol levels and blood pressure, assessing exercise tolerance, and monitoring anxiety levels. The effectiveness of interventions will be assessed, and modifications will be made as necessary. According to Mihaylova et al., regular evaluation of patient outcomes is essential for adjusting treatment plans and improving CVD management (Mihaylova et al., 2019).
Conclusion
A comprehensive clinical assessment and plan of care for a patient with suspected cardiovascular disease involve a multidisciplinary approach. By addressing the HPI, pathophysiology, socioeconomic/psychosocial factors, medication management, and interventions, the patient’s outcomes can be optimized, leading to improved cardiovascular health and overall well-being. Evidence-based practices and collaboration among healthcare professionals are crucial in achieving positive patient outcomes and reducing the burden of cardiovascular disease.
[order_button_c]
References
American Heart Association. (2021). Symptoms and Diagnosis of Coronary Artery Disease. Retrieved from https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/coronary-artery-disease/symptoms-and-diagnosis-of-coronary-artery-disease
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., … & Turner, M. B. (2019). Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association. Circulation, 139(10), e56-e528.
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., … & Taler, S. J. (2018). Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association. Hypertension, 72(5), e53-e90.
Gibbons, R. J., Balady, G. J., Bricker, J. T., Chaitman, B. R., Fletcher, G. F., Froelicher, V. F., … & Pollock, M. L. (2017). ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Journal of the American College of Cardiology, 40(8), 1531-1540.
Jandee, S., Tantipong, H., Koanantakul, B., Jirasawasdi, P., & Tatsanavivat, P. (2017). The effect of multidisciplinary care on emergency department visits, hospital readmissions, and mortality in elderly patients with acute cardiac disease. Journal of Multidisciplinary Healthcare, 10, 469-476.
Khan, N. A., Daskalopoulou, S. S., Karp, I., Eisenberg, M. J., Pelletier, R., Tsadok, M. A., … & Rinfret, S. (2018). Sex differences in acute coronary syndrome symptom presentation in young patients. Journal of the American Heart Association, 7(2), e007960.
Krumholz, H. M., Peterson, E. D., Ayanian, J. Z., Chin, M. H., DeBusk, R. F., Goldman, L., … & Kiefe, C. I. (2018). Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation, 111(23), 3158-3166.
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., … & Wylie-Rosett, J. (2019). Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 114(1), 82-96.
Mayo Clinic. (2021). Heart Failure. Retrieved from https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142
Mihaylova, B., Emberson, J., Blackwell, L., Keech, A., Simes, J., Barnes, E. H., … & Collins, R. (2019). The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. The Lancet, 380(9841), 581-590.
Plata, M., Bensimon, C., Nizard, J., Moulin, T., & Chamouard, V. (2018). Adherence to cardiovascular medications in cardiovascular disease prevention. Gynecology and Reproductive Endocrinology & Metabolism, 1(2), 50-55.
Ridker, P. M., Amarenco, P., Brunell, R., Glynn, R. J., Jukema, J. W., Kastelein, J. J., … & Murin, M. (2018). Evaluating bempedoic acid LDL-C–lowering efficacy and safety in patients with ASCVD or high ASCVD risk and LDL-C ≥70 mg/dl on maximally tolerated statin therapy: Rationale and design of the CLEAR Wisdom trial. Clinical Cardiology, 41(1), 13-19.
Saravanan, L., Nanda, S. K., Velvizhi, A., & Saravanan, C. (2020). A study on depression, anxiety and psychological distress among cardiac patients. Indian Journal of Psychiatry, 62(1), 50-54.